Health Care Facilities

YONGHE MEDICAL

Everbright Medical Reverses Losses and Optimizes Business Models

雍禾医疗 achieves annual profitability, hair economy shifts to female self-appreciation consumption

YONGHE MEDICAL released FY2025 9 Months Earnings on March 31 (BJT), with actual revenue of HKD 1.45 B and EPS of HKD 0.1096

YONGHE MEDICAL released FY2025 Q3 earnings on March 31, 2026 (BJT), actual revenue HKD 517.5 M, actual EPS HKD 0.0491

YONGHE MEDICAL released FY2025 annual earnings on March 31 After-Market (BJT), actual revenue HKD 1.976 B (forecast HKD 2.056 B), actual EPS HKD 0.161 (forecast HKD 0.066)

YONGHE MEDICAL released FY2025 Q4 earnings on March 31 After-Market (BJT), actual revenue HKD 526.43 M, actual EPS HKD 0.05

Yonghe Medical Announces Profitable 2025 Annual Results

YONGHE MEDICAL to Release FY2025 Earnings on March 31 After-Market (BJT), Forecast Revenue HKD 1.98 B, EPS HKD 0.066

Yonghe Medical Group Predicts Annual Net Profit of at Least RMB 70 Million

YONGHE MEDICAL released FY2025 Q1 earnings on August 27, 2025 (BJT) with actual revenue of HKD 461.35 M and EPS of HKD 0.0298

YONGHE MEDICAL released FY2025 Semi-Annual Earnings on August 27 After-Market (BJT), with actual revenue of HKD 932.84 M and EPS of HKD 0.0604

YONGHE MEDICAL released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue HKD 471.49 M, actual EPS HKD 0.0305

Yonghe Medical Announces First Half of 2025 Earnings: Revenue at RMB 862 Million, Profit Reverses Loss

YONGHE MEDICAL FY2025 Semi-Annual Earnings Release on August 27, 2025 (BJT)

Yonghe Medical Reports Revenue Growth and Narrowing Net Loss in 2024

Yonghe Medical Group Holds Annual General Meeting and Approves Multiple Proposals

Yonghe Medical cancels 47,000 repurchased shares

雍禾 Medical Deepens Partnership with Meituan for Hair Health

Yonghe Medical Reports Improved Performance in 2024 with Digital Transformation

Yonghe Medical Releases 2024 Annual Report, Emphasizing Strategic Shift and Business Development

FAMEGLOW

HAICHANG HLDG

NEW GONOW RV

TJCD

ZHONGSHENJIANYE

HUISHENG INTL

EASYHOLD GROUP

CH CITY INFRA

51WORLD

INTELLIMARK W27

Ordinary dividend (cash)

Ex Date: 2026.05.26, Cash dividend 0.086 HKD

01432

02279

As global markets respond to strong U.S. labor data and corporate earnings, Asian penny stocks are gaining investor interest. These stocks, representing smaller companies, may offer significant value. Key stocks include Guoquan Food, Yonghe Medical Group, and China Shengmu Organic Milk, among others, each with varying market caps and financial health ratings. Despite challenges like net losses and declining earnings, some companies show potential for recovery and growth. Investors are encouraged to explore these opportunities in the Asian penny stock market.

Simplywall

CHINA SHENGMU

GUOQUAN

LEVER STYLE

TK GROUP HLDG

CNMC Goldmine

YZJ Shipbldg SGD

TeleChoice

Fenglin Group

Northglass

YZJ Shipbldg RMB

Asian Penny Stocks To Watch In May 2026

516610

In a report released yesterday, from CICC maintained a Buy rating on Yonghe Medical Group Co., Ltd., with a price target of HK$2.46.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Yonghe Medical Group Co., Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of HK$2.46.

Tip Ranks

Dacheng CSI All Share Health Care Equipment and Services ETF

CICC Remains a Buy on Yonghe Medical Group Co., Ltd. (2279)

- After years of strategic adjustments, China's first publicly listed hair transplant company, YONGHE Medical, has achieved a turnaround in financial performance.  
- In 2025, the group reported total revenue of 1.808 billion RMB, a slight increase of 0.2% year-on-year, with profit rebounding to 74 million RMB from a previous loss.  
- The company's focus has shifted from expanding store numbers to enhancing profitability at established outlets, resulting in a significant rise in gross margin and a reduction in marketing costs.

Wallstreetcn

Interview with YONGHE MEDICAL Founder Zhang Yu: China's Hair Transplant Technology Leads by a Wide Margin, but YONGHE's Next Growth Point is Not on the Operating Table

Yonghe Medical Moves to Modernize Governance With New Articles of Association

Yonghe Medical Moves to Modernize Governance With New Articles of Association

YONGHE MEDICAL announced its full-year results for the year ended December last year, with a revenue of RMB 1.808 billion, an increase of 0.2% year-on-year. It turned a loss into a profit, earning RMB 73.711 million, compared to a loss of RMB 226 million in the same period last year; earnings per share were RMB 0.15. A final dividend of RMB 0.076 was declared

AASTOCKS

"Performance" YONGHE MEDICAL turned a loss into a profit of 73.711 million RMB for the whole year, with a final dividend of 0.076 RMB

000813

Global markets faced volatility, with major indices declining due to geopolitical tensions. Investors are turning to penny stocks, which represent smaller companies with potential value. Notable penny stocks include Yonghe Medical Group, HG Metal Manufacturing, and Dezhan Healthcare, each with unique financial profiles and growth prospects. Yonghe Medical Group, focused on hair healthcare in China, shows strong cash flow despite being unprofitable. HG Metal Manufacturing, trading in steel products, demonstrates financial stability and growth. Dezhan Healthcare, specializing in cardiovascular drugs, remains pre-revenue but maintains strong liquidity. These stocks offer opportunities amidst market uncertainty.

DEZHAN HEALTHCARE

HG Metal

Global Penny Stocks: 3 Hidden Gems With Market Caps Under US$2B

Yonghe Medical Group Co., Ltd. has released a supplemental announcement to its 2024 Annual Report. The update details the company's contractual arrangements and treasury shares, including control over certain VIE entities and plans to use treasury shares for employee share schemes and capital management.

Yonghe Medical Group Releases Supplemental Information on 2024 Annual Report

Yonghe Medical Group Co., Ltd. (HK:2279) has announced its board composition, including executive, non-executive, and independent non-executive directors. The announcement outlines the roles within the audit, remuneration, and nomination committees, providing stakeholders with insights into governance and leadership, which may influence the company's strategic direction and operational efficiency. The current market cap is HK$1.08B with an average trading volume of 585,707 and a technical sentiment signal indicating a 'Buy'.

Yonghe Medical Group Announces Board Composition and Roles

According to the Zhitong Finance APP, YONGHE MEDICAL announced that starting from October 28, 2025, the composition of the company's nomination committee (Nomination Committee) will change as follows: Independent non-executive director Mr. Li Xiaopei will no longer serve as a member of the Nomination Committee; Independent non-executive director Ms. Liang Jihong has been appointed as a member of the Nomination Committee

Zhitong

YONGHE MEDICAL: Independent non-executive director Liang Jihong appointed as a member of the nomination committee

YONGHE MEDICAL(02279.HK)

Asian Penny Stocks To Watch In May 2026

CICC Remains a Buy on Yonghe Medical Group Co., Ltd. (2279)

Interview with YONGHE MEDICAL Founder Zhang Yu: China's Hair Transplant Technology Leads by a Wide Margin, but YONGHE's Next Growth Point is Not on the Operating Table

Yonghe Medical Moves to Modernize Governance With New Articles of Association

"Performance" YONGHE MEDICAL turned a loss into a profit of 73.711 million RMB for the whole year, with a final dividend of 0.076 RMB

Global Penny Stocks: 3 Hidden Gems With Market Caps Under US$2B

Yonghe Medical Group Releases Supplemental Information on 2024 Annual Report

Yonghe Medical Group Announces Board Composition and Roles

YONGHE MEDICAL: Independent non-executive director Liang Jihong appointed as a member of the nomination committee

Trending